HLS Therapeutics Inc News

HLS Therapeutics Inc Price Target Cut to C$3.25/Share From C$3.75 by Stifel Nicolaus

Dow JonesAug 13 23:55

Strategic Divestiture and Financial Flexibility: HLS Therapeutics Inc's Optimistic Buy Rating

TipRanksJul 3 20:40

Stifel Nicolaus Keeps Their Hold Rating on HLS Therapeutics Inc (HLS)

TipRanksJul 3 19:52

HLS Therapeutics Downgraded to Hold at Stifel GMP on Revenue Concerns; Price Target Cut to C$5.00

MT NewswiresNov 10, 2023 22:47

HLS Therapeutics Inc (HLS) Receives a Buy From Stifel Nicolaus

TipRanksNov 7, 2023 22:10

Bloom Burton Remains a Buy on HLS Therapeutics Inc (HLS)

TipRanksAug 13, 2023 18:20

Clarus Sticks to Its Buy Rating for HLS Therapeutics Inc (HLS)

TipRanksAug 11, 2023 22:20

HLS Therapeutics Inc (HLS) Gets a Buy Rating From Stifel Nicolaus

TipRanksAug 11, 2023 04:30

Stifel Nicolaus Remains a Buy on HLS Therapeutics Inc (HLS)

TipRanksJul 11, 2023 05:10

Stifel Nicolaus Keeps Their Buy Rating on HLS Therapeutics Inc (HLS)

TipRanksJun 22, 2023 22:30

Stifel Nicolaus Keeps Their Buy Rating on HLS Therapeutics Inc (HLS)

TipRanksJun 12, 2023 22:30

HLS Therapeutics Inc (HLS) Receives a Buy From Clarus

TipRanksMay 12, 2023 20:50

HLS Therapeutics Inc (HLS) Receives a Buy From Stifel Nicolaus

TipRanksMay 11, 2023 23:41